Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
Top Cited Papers
Open Access
- 7 January 2024
- journal article
- review article
- Published by Springer Nature in Biomarker Research
- Vol. 12 (1) , 1-22
Abstract
The cGAS-STING signaling pathway has emerged as a critical mediator of innate immune responses, playing a crucial role in improving antitumor immunity through immune effector responses. Targeting the cGAS-STING pathway holds promise for overcoming immunosuppressive tumor microenvironments (TME) and promoting effective tumor elimination. However, systemic administration of current STING agonists faces challenges related to low bioavailability and potential adverse effects, thus limiting their clinical applicability. Recently, nanotechnology-based strategies have been developed to modulate TMEs for robust immunotherapeutic responses. The encapsulation and delivery of STING agonists within nanoparticles (STING-NPs) present an attractive avenue for antitumor immunotherapy. This review explores a range of nanoparticles designed to encapsulate STING agonists, highlighting their benefits, including favorable biocompatibility, improved tumor penetration, and efficient intracellular delivery of STING agonists. The review also summarizes the immunomodulatory impacts of STING-NPs on the TME, including enhanced secretion of pro-inflammatory cytokines and chemokines, dendritic cell activation, cytotoxic T cell priming, macrophage re-education, and vasculature normalization. Furthermore, the review offers insights into co-delivered nanoplatforms involving STING agonists alongside antitumor agents such as chemotherapeutic compounds, immune checkpoint inhibitors, antigen peptides, and other immune adjuvants. These platforms demonstrate remarkable versatility in inducing immunogenic responses within the TME, ultimately amplifying the potential for antitumor immunotherapy.Keywords
Funding Information
- science and technology innovation Program of Hunan Province (2022RC1210 and 2021RC3029, 2022RC1210 and 2021RC3029)
- Natural Science Foundation of Hunan Province (2023JJ30959)
- National Natural Science Foundation of China (82272659)
- China Postdoctoral Science Foundation ((2021T140754 and 2020M672521)
This publication has 160 references indexed in Scilit:
- The mechanism of double-stranded DNA sensing through the cGAS-STING pathwayCytokine & Growth Factor Reviews, 2014
- Toll-Like Receptor Signaling PathwaysFrontiers in Immunology, 2014
- Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programmingThe EMBO Journal, 2014
- Cyclic GMP-AMP Synthase Is Activated by Double-Stranded DNA-Induced OligomerizationImmunity, 2013
- Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic AcidThe Journal of Immunology, 2013
- Liposome: classification, preparation, and applicationsDiscover Nano, 2013
- 5,6-Dimethylxanthenone-4-acetic Acid (DMXAA) Activates Stimulator of Interferon Gene (STING)-dependent Innate Immune Pathways and Is Regulated by Mitochondrial Membrane PotentialJournal of Biological Chemistry, 2012
- Doxil® — The first FDA-approved nano-drug: Lessons learnedJournal of Controlled Release, 2012
- Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor PenetrationAngewandte Chemie International Edition, 2011
- Toll‐like Receptor and RIG‐1‐like Receptor SignalingAnnals of the New York Academy of Sciences, 2008